CTTH
Ctt Pharmaceutical Holdings, Inc.
Ctt Pharmaceutical Holdings, Inc. insider trading
Insiders at Ctt Pharmaceutical Holdings, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Ctt Pharmaceutical Holdings, Inc. (CEO) buying $175 of CTTH, filed Sep 10, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $175
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 10, 2026
From SEC filings · last 30 days
Recent CTTH insider transactions
Ctt Pharmaceutical Holdings, Inc.CEO
Bought 3,500 sh at $0.05 · Sep 10, 2026
$175
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
CTTH insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, one insider traded CTTH on the open market: 33 purchases worth $26.9K and 0 sales. In the last four quarters alone: 8 purchases ($14.9K) and 0 sales, by one insider.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | — | — | |
| Q4 2025 | +$11.4K4 buys | — | |
| Q3 2025 | +$3.5K4 buys | — | |
| Q2 2025 | +$6.5K4 buys | — | |
| Q1 2025 | +$2.8K4 buys | — | |
| Q4 2024 | +$1.4K1 buy | — | |
| Q3 2024 | +$1.3K16 buys | — |
- Largest purchase
- +$8K of CTTH by Ctt Pharmaceutical Holdings, Inc. (Director) on Nov 20, 2025.
Open-market transactions through Jun 30, 2026most recent first
Ctt Pharmaceutical Holdings, Inc.
CEO
+$498
Dec 17, 2025
8,300 sh · $0.06
Ctt Pharmaceutical Holdings, Inc.
Director
+$8K
Nov 20, 2025
200,000 sh · $0.04
Ctt Pharmaceutical Holdings, Inc.
CEO
+$2.5K
Nov 20, 2025
62,900 sh · $0.04
Ctt Pharmaceutical Holdings, Inc.
CEO
+$420
Oct 31, 2025
7,000 sh · $0.06
Ctt Pharmaceutical Holdings, Inc.
CEO
+$409
Sep 23, 2025
6,817 sh · $0.06
Ctt Pharmaceutical Holdings, Inc.
CEO
+$2.2K
Aug 02, 2025
44,080 sh · $0.05
Ctt Pharmaceutical Holdings, Inc.
CEO
+$632
Aug 01, 2025
15,800 sh · $0.04
Ctt Pharmaceutical Holdings, Inc.
CEO
+$240
Jul 08, 2025
8,000 sh · $0.03
Ctt Pharmaceutical Holdings, Inc.
CEO
+$1.2K
Jun 26, 2025
39,600 sh · $0.03
Ctt Pharmaceutical Holdings, Inc.
CEO
+$483
Jun 23, 2025
16,100 sh · $0.03
Ctt Pharmaceutical Holdings, Inc.
CEO
+$4.1K
Jun 09, 2025
82,160 sh · $0.05
Ctt Pharmaceutical Holdings, Inc.
CEO
+$699
Apr 09, 2025
9,986 sh · $0.07
Ctt Pharmaceutical Holdings, Inc.
CEO
+$776
Mar 31, 2025
15,520 sh · $0.05
Ctt Pharmaceutical Holdings, Inc.
CEO
+$324
Mar 11, 2025
5,400 sh · $0.06
Ctt Pharmaceutical Holdings, Inc.
CEO
+$1.1K
Mar 07, 2025
11,956 sh · $0.09
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Dec 17, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 8,300 | $0.06 | +$498 |
| Nov 20, 2025 | Ctt Pharmaceutical Holdings, Inc.Director | 200,000 | $0.04 | +$8K |
| Nov 20, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 62,900 | $0.04 | +$2.5K |
| Oct 31, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 7,000 | $0.06 | +$420 |
| Sep 23, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 6,817 | $0.06 | +$409 |
| Aug 02, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 44,080 | $0.05 | +$2.2K |
| Aug 01, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 15,800 | $0.04 | +$632 |
| Jul 08, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 8,000 | $0.03 | +$240 |
| Jun 26, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 39,600 | $0.03 | +$1.2K |
| Jun 23, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 16,100 | $0.03 | +$483 |
| Jun 09, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 82,160 | $0.05 | +$4.1K |
| Apr 09, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 9,986 | $0.07 | +$699 |
| Mar 31, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 15,520 | $0.05 | +$776 |
| Mar 11, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 5,400 | $0.06 | +$324 |
| Mar 07, 2025 | Ctt Pharmaceutical Holdings, Inc.CEO | 11,956 | $0.09 | +$1.1K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check CTTH — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Ctt Pharmaceutical Holdings, Inc. is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are CTTH insiders buying or selling?
- Between Sep 10, 2026 and Sep 10, 2026, 1 Ctt Pharmaceutical Holdings, Inc. insider made 1 open-market purchase worth $175 and no sales, a net purchase of $175.
- How much CTTH stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 1 Ctt Pharmaceutical Holdings, Inc. insider made 33 open-market purchases worth $26.9K and no sales. In the four quarters to Jun 30, 2026: 8 purchases ($14.9K) and no sales. The largest purchase was Ctt Pharmaceutical Holdings, Inc. buying $8K on Nov 20, 2025.
- What was the largest recent CTTH insider trade?
- Ctt Pharmaceutical Holdings, Inc. (CEO) bought $175 of CTTH stock on Sep 10, 2026 at about $0.05 a share.
- When did an insider last buy CTTH shares?
- The most recent open-market purchase on file is Ctt Pharmaceutical Holdings, Inc. (CEO) buying $175 on Sep 10, 2026.
- Where does CTTH insider trading data come from?
- From the Form 4 filings Ctt Pharmaceutical Holdings, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
The week's real signals — open-market insider buys, cluster formations and what insiders did in CTTH and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.